Sleep duration, cardiovascular disease, and proinflammatory biomarkers
Michael A Grandner,1,2 Megan R Sands-Lincoln,3 Victoria M Pak,2,4 Sheila N Garland1,5 1Behavioral Sleep Medicine Program, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, PA, USA; 2Center for Sleep and Circadian Neurobiology, University of Pennsylvania, PA, USA; 3Ce...
Main Authors: | Grandner MA, Sands-Lincoln MR, Pak VM, Garl, SN |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-07-01
|
Series: | Nature and Science of Sleep |
Online Access: | http://www.dovepress.com/sleep-duration-cardiovascular-disease-and-proinflammatory-biomarkers-a13727 |
Similar Items
-
SLEEP DURATION AND CARDIOVASCULAR RISK
by: Mihaela Daniela Baltă, et al.
Published: (2018-09-01) -
Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP.
by: Wessel M A van Leeuwen, et al.
Published: (2009-01-01) -
The impact of mindfulness-based interventions on symptom burden, positive psychological outcomes, and biomarkers in cancer patients
by: Rouleau CR, et al.
Published: (2015-06-01) -
Association of Duration of Sleep and Cardiovascular and Metabolic Comorbidities in Sleep Apnea Syndrome
by: Zeynep Zeren Ucar, et al.
Published: (2012-01-01) -
Abnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients
by: Yang Li, et al.
Published: (2021-03-01)